デフォルト表紙
市場調査レポート
商品コード
1722611

水頭症シャント市場レポート:タイプ別、製品タイプ別、年齢層別、エンドユーザー別、地域別、2025年~2033年

Hydrocephalus Shunts Market Report by Type, Product Type, Age Group, End User, and Region 2025-2033


出版日
発行
IMARC
ページ情報
英文 140 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.28円
水頭症シャント市場レポート:タイプ別、製品タイプ別、年齢層別、エンドユーザー別、地域別、2025年~2033年
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

水頭症シャントの世界市場規模は2024年に4億6,720万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに6億4,210万米ドルに達し、2025年から2033年にかけて3.42%の成長率(CAGR)を示すと予測しています。同市場は主に、水頭症の罹患率の上昇、ヘルスケアの高度化、シャント設計の技術革新によって牽引されています。さらに、先天性水頭症患者の増加と小児人口の急速な増加が市場成長を大きく促進しています。

水頭症シャント市場分析:

  • 主な市場促進要因:水頭症シャント市場規模は、ヘルスケアインフラの進歩、水頭症の有病率の上昇、シャント開発の技術進歩によって牽引されています。これに伴い、老年人口と小児人口の増加が市場の拡大に大きく寄与しています。さらに、好都合な返済政策や早期治療・発見法に関する意識の高まりが、市場の成長をさらに促進しています。また、水頭症を含む神経変性疾患の調査に多額の投資が行われ、効果的なシャントソリューションの技術革新や製造が促されていることも、市場規模の拡大に極めて重要な役割を果たしています。
  • 主な市場動向:水頭症シャント市場の主な動向には、患者の予後改善に拍車をかけるアンチサイフォンやプログラマブルシャントなどの最先端技術の急速な統合が含まれます。新興国では、ヘルスケア支出やインフラの充実により需要が拡大しています。また、小児水頭症患者の急増も特殊シャントの需要を後押ししています。さらに、研究開発への多額の投資が、革新的な製品設計を生み出す原動力となっています。同時に、意識の高まりと診断率の向上が、迅速な介入を必要とする症例を特定することで市場の成長に拍車をかけています。
  • 地理的動向:北米は、優れたヘルスケアシステムと相まって水頭症の症例が増加しており、世界の水頭症市場分析において堅調な成長を示しています。米国はソリューションの研究開発と革新的な医療機器の普及でリードしています。有利な償還プロトコルと専門医療提供者の強力なネットワークがこの市場をさらに押し上げ、北米は世界の水頭症シャント市場において支配的な地域となっています。
  • 課題と機会:世界の水頭症市場概要に見られる主な課題には、必要な技術の進歩、再手術率の増加、重大な合併症などがあります。しかし、このような課題は、特に再手術率の低い生体適合性やプログラム可能なシャントの製造など、技術革新の機会を提供しています。水頭症の診断と認知度の向上、新興国におけるヘルスケアの普及は、さらに大きな成長機会を生み出しています。さらに、研究機関や組織における資金調達は競争力を高め、患者の転帰を改善することができます。

水頭症シャント市場動向:

先天性疾患と小児人口の増加

水頭症シャントの世界市場シェアにおける重要な動向は、乳幼児や小児における先天性水頭症の有病率の増加です。さらに、小児人口の急増も市場力学において極めて重要な役割を果たしています。The World Countsによると、毎日38万5,000人、すなわち年間1億4,000万人の赤ちゃんが誕生しています。先天性疾患の増加が、小児用シャント・ソリューションの需要を押し上げています。ジョン・ホプキンス病院によると、米国では1,000人に1人か2人が先天性水頭症だといいます。その結果、メーカーは現在、この年齢層特有の生理学的・解剖学的ニーズを考慮し、小児・乳児専用のシャントの設計に力を入れています。

先端技術の急速な採用

世界の水頭症シャント市場は、サイフォン防止シャントやプログラマブルシャントなどの先端技術の採用が急増している顕著な動向を目の当たりにしています。このような技術革新は、脳脊髄液の流れを正確に調整することで、患者の予後を改善します。Journal of Neurosurgery誌に掲載された調査論文によると、プログラム可能なシャントは水頭症治療において、プログラム不可能なシャントよりも再手術率が低いです。その結果、プログラム可能なシャントの方が費用対効果が高いことが証明されています。調査によると、プログラム可能なシャントを使用した患者の7%に再手術が必要であったのに対し、プログラム不可能なシャントを使用した患者では21.6%に再手術が必要でした。さらに、遠隔モニタリングや遠隔医療システムの導入により、術後のケアが向上し、頻繁な通院の必要性が低下するため、さらに普及が進んでいます。

新興国における製品の普及率の増加

水頭症の世界市場シェアは、主にヘルスケア支出の増加とヘルスケアインフラの強化により、新興国市場で明るい見通しが見えています。中国やインドのような国々では、患者意識の高まりと医療施設の改善により、水頭症シャントの普及率が上昇しています。業界レポートによると、アジア太平洋地域は2024年に堅調な経済成長を示すと予測されており、インドのGDPは5%成長すると推定されています。市場の拡大は、ヘルスケア施設を強化する政府の取り組みや、満たされていない医療需要への対応を目標とするこれらの経済圏における大手企業のプレゼンス強化によってさらに推進されます。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の水頭症シャント市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:タイプ別

  • 脳室腹膜
  • 心室房
  • 脳室胸膜
  • 腰腹膜

第7章 市場内訳:製品タイプ別

  • 水頭症弁
    • 主要セグメント
      • 調整可能圧力バルブ
      • 固定圧力バルブ
  • 水頭症カテーテル

第8章 市場内訳:年齢別

  • 乳児
  • 子供
  • 大人

第9章 市場内訳:エンドユーザー別

  • 病院
  • 外来手術センター

第10章 市場内訳:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳:国別

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Argi Group
    • B. Braun Melsungen AG
    • Christoph Miethke GmbH & Co. KG
    • G. Surgiwear Ltd.
    • HLL Lifecare Limited
    • Integra LifeSciences
    • Kaneka Medix Corporation(Kaneka Corporation)
    • Medtronic Plc
    • Natus Medical Incorporated
    • Sophysa
    • Spiegelberg GmbH & Co. KG(SHS Medizintechnik Holding GmbH)
    • TKB Corporation
図表

List of Figures

  • Figure 1: Global: Hydrocephalus Shunts Market: Major Drivers and Challenges
  • Figure 2: Global: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Hydrocephalus Shunts Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Hydrocephalus Shunts Market: Breakup by Product Type (in %), 2024
  • Figure 6: Global: Hydrocephalus Shunts Market: Breakup by Age Group (in %), 2024
  • Figure 7: Global: Hydrocephalus Shunts Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Hydrocephalus Shunts Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Hydrocephalus Shunts (Ventriculo-Peritoneal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Hydrocephalus Shunts (Ventriculo-Peritoneal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Hydrocephalus Shunts (Ventriculo-Atrial) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Hydrocephalus Shunts (Ventriculo-Atrial) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Hydrocephalus Shunts (Ventriculo-Pleural) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Hydrocephalus Shunts (Ventriculo-Pleural) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Hydrocephalus Shunts (Lumbo-Peritoneal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Hydrocephalus Shunts (Lumbo-Peritoneal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Hydrocephalus Shunts (Hydrocephalus Valves) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Hydrocephalus Shunts (Hydrocephalus Valves) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Hydrocephalus Shunts (Hydrocephalus Catheters) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Hydrocephalus Shunts (Hydrocephalus Catheters) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Hydrocephalus Shunts (Infants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Hydrocephalus Shunts (Infants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Hydrocephalus Shunts (Children) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Hydrocephalus Shunts (Children) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Hydrocephalus Shunts (Adults) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Hydrocephalus Shunts (Adults) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Hydrocephalus Shunts (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Hydrocephalus Shunts (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Hydrocephalus Shunts (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Hydrocephalus Shunts (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: North America: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: North America: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: United States: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: United States: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Canada: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Canada: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Asia-Pacific: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Asia-Pacific: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: China: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: China: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Japan: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Japan: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: India: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: India: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: South Korea: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: South Korea: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Australia: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Australia: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Indonesia: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Indonesia: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Others: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Others: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Europe: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Europe: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Germany: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Germany: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: France: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: France: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: United Kingdom: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: United Kingdom: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Italy: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Italy: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Spain: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Spain: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Russia: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Russia: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Latin America: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Latin America: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Brazil: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Brazil: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Mexico: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Mexico: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Others: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Others: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Middle East and Africa: Hydrocephalus Shunts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Middle East and Africa: Hydrocephalus Shunts Market: Breakup by Country (in %), 2024
  • Figure 79: Middle East and Africa: Hydrocephalus Shunts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Global: Hydrocephalus Shunts Industry: SWOT Analysis
  • Figure 81: Global: Hydrocephalus Shunts Industry: Value Chain Analysis
  • Figure 82: Global: Hydrocephalus Shunts Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Hydrocephalus Shunts Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Hydrocephalus Shunts Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Hydrocephalus Shunts Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 4: Global: Hydrocephalus Shunts Market Forecast: Breakup by Age Group (in Million USD), 2025-2033
  • Table 5: Global: Hydrocephalus Shunts Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Hydrocephalus Shunts Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Hydrocephalus Shunts Market: Competitive Structure
  • Table 8: Global: Hydrocephalus Shunts Market: Key Players
目次
Product Code: SR112025A5226

The global hydrocephalus shunts market size reached USD 467.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 642.1 Million by 2033, exhibiting a growth rate (CAGR) of 3.42% during 2025-2033. The market is primarily driven by the rising incidence of hydrocephalus, advanced healthcare infrastructure, and technological innovations in shunts design. Moreover, increasing cases of congenital hydrocephalus and rapid proliferation of pediatric population are significantly driving the market growth.

Hydrocephalus Shunts Market Analysis:

  • Major Market Drivers: The hydrocephalus shunts market size is driven by advancing healthcare infrastructure, escalating prevalence of hydrocephalus, and technological advancements in shunt development. In line with this, the growing geriatric and pediatric populations are substantially aiding the market toward expansion. Additionally, preferable money repayment policies and surge in awareness about early treatment and detection methods further spur market growth. Heavy investments in research of neurogenerative diseases, including hydrocephalus, prompting innovations and manufacturing of effective shunt solutions, also play a pivotal role in expanding the hydrocephalus shunts market size.
  • Key Market Trends: Some of the major hydrocephalus shunts market trends involve rapid integration of cutting-edge technology, including anti-siphon and programmable shunts, spurred by their improved patient outcomes. There is an escalating demand in emerging economies primarily due to enhancing healthcare expenditure and infrastructure. Surge in pediatric hydrocephalus incidents is also propelling the demand for specialized shunts. Moreover, substantial investments in R&D are driving the creation of innovative product designs. Concurrently, heightened awareness and improved diagnostic rates are fueling the market growth by identifying cases that require prompt intervention.
  • Geographical Trends: North America is depicting a robust growth in the global hydrocephalus market analysis due to the rising cases of hydrocephalus in the region, coupled with superior healthcare systems. The United Sates leads in the research and development of hydrocephalus shunts solutions and the widespread adoption of innovative medical equipment. Advantageous reimbursement protocols and a strong network of professional healthcare providers further boost this market, establishing North America as a dominant region in the global hydrocephalus shunt market.
  • Competitive Landscape: Some of the major market players in the hydrocephalus industry include Argi Group, B. Braun Melsungen AG, Christoph Miethke GmbH & Co. KG, G. Surgiwear Ltd., HLL Lifecare Limited, Integra LifeSciences, Kaneka Medix Corporation (Kaneka Corporation), Medtronic Plc, Natus Medical Incorporated, Sophysa, Spiegelberg GmbH & Co. KG (SHS Medizintechnik Holding GmbH), and TKB Corporation, among many others.
  • Challenges and Opportunities: The prime challenges witnessed in the global hydrocephalus market overview include requisite technological advancements, increased revision rates, and critical complications. Nonetheless, such challenges offer opportunities for innovations, especially in manufacturing biocompatible and programmable shunts that have lower revision rates. The increasing diagnosis and awareness of hydrocephalus, together with proliferating healthcare infrastructure in emerging countries, further generate substantial growth opportunities. Moreover, funding in research institutes and organizations can enhance competitiveness and positive patient outcomes.

Hydrocephalus Shunts Market Trends:

Increasing Congenital Cases and Pediatric Population

A significant trend in the global hydrocephalus shunts market share is the increasing prevalence of congenital hydrocephalus among infants and children. In addition, rapid growth in pediatric population is also playing a pivotal role in market dynamics. According to The World Counts, each day 385,000 babies are born, i.e., 140 million a year. The heightening incidents of congenital cases has boosted the demand for pediatric shunt solutions. According to John Hopkins Hospital, 1 or 2 of every 1000 infants born in U.S. have congenital hydrocephalus. As a result, manufacturers are currently emphasizing on designing specialized shunts for children and infants, acknowledging the distinct physiological and anatomical needs of this age group.

Rapid Adoption of Advanced Technologies

The global hydrocephalus shunts market is witnessing a notable trend towards the escalating adoption of advanced technologies, including anti-siphon and programmable shunts. Such innovations improve patient outcomes by permitting accurate adjustments of cerebrospinal fluid flow. According to a research article published in the Journal of Neurosurgery, programmable shunts depict lower revision rates than nonprogrammable shunts for the treatment of hydrocephalus. Consequently, programmable shunts are proven to be more cost-efficient. The research showed that 7% of patients with programmable shunts needed revisions, while 21.6% of patients with nonprogrammable shunts required revisions. Additionally, the incorporation of remote monitoring and telehealth systems is further driving adoption by improving post-operative care and lowering the need for frequent hospital visits.

Increasing Product Prevalence in Emerging Economies

The global hydrocephalus market share is witnessing a positive outlook in emerging market principally due to increase in healthcare spending and enhanced healthcare infrastructure. Countries like China and India are undergoing elevated adoption rates of hydrocephalus shunts primarily because of heightening patient awareness and improved medical facilities. As per industry reports, Asia Pacific is projected to depict a robust economic growth in 2024 with India's GDP estimated to grow by 5%. The market expansion is further propelled by government initiatives to enhance healthcare facilities and the strengthening presence of major companies in these economies, targeting to address the unmet medical demands.

Hydrocephalus Shunts Market Segmentation:

Breakup by Type:

  • Ventriculo-Peritoneal
  • Ventriculo-Atrial
  • Ventriculo-Pleural
  • Lumbo-Peritoneal

Ventriculo-peritoneal accounts for the majority of the market share

The ventriculo-peritoneal (VP) represents the majority of the global hydrocephalus shunts market share as it is reliable, highly effective, and is largely accepted in clinical applications. VP shunts demonstrate high success rates in patients with hydrocephalus, aiding in strengthening its dominance in the market dynamics. The widespread utilization of VP shunts in adults as well as pediatrics further facilitate their market growth. As per a clinical report, approximately 750,000 individuals are diagnosed with hydrocephalus, while 160,000 VP shunts are implanted each year globally. Moreover, the robust support from medical professionals and advantageous healthcare policies assists in sustaining hydrocephalus shunts market share and growth.

Breakup by Product Type:

  • Hydrocephalus Valves
    • Adjustable Pressure Valves
    • Fix Pressure Valves
  • Hydrocephalus Catheters

Hydrocephalus valves hold the largest share of the industry

Hydrocephalus valves play a critical role in regulating the flow of cerebrospinal fluid. Valves are integral component of hydrocephalus shunt system as they aid in maintaining intracranial pressure. Adjustable pressure valves have flexible built, designed to address pressure settings as per the patient needs. Fixed pressure valves are comparatively less versatile but are cost-efficient and reliable. Advancements in manufacturing technology of valves and innovations further strengthen the segment's growth in the global hydrocephalus shunts market share. For instance, Integra LifeSciences has innovated the valves design by manufacturing various variants of fixed pressure valves, including Ultra VS valves, Pudenz Valves, Mishler On/Off valves, and CODMAN HAKIM Precision Fixed Pressure Valves.

Breakup by Age Group:

  • Infants
  • Children
  • Adults

Children represent the leading market segment

Children hold the largest segment in the global hydrocephalus shunts market share due to an elevated prevalence of congenital hydrocephalus and the intense demand for early detection and treatment. According to the National Institutes of Health, it is estimated that each year approximately 400,000 new cases of pediatric hydrocephalus will develop globally. Furthermore, according to a research article published in the Journal of Neurosurgey, Asia also depicts prevalence of pediatric hydrocephalus. In the study, 29% of nonpostinfectious hydrocephalus and 10.7% of postinfectious hydrocephalus were identified across Asia. Specialized shunt systems and development in pediatric neurosurgery for children plays a pivotal role in hydrocephalus shunts market dynamics. Additionally, intensifying awareness about neurogenerative diseases in children and enhanced diagnostics techniques facilitates the segment dominance.

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers

Hospitals exhibit a clear dominance in the market

Hospitals hold the largest segment as an end user in the global hydrocephalus shunts market forecast because of their superior medical infrastructure, ability to execute critical surgeries, and competent healthcare professionals. Hospitals greatly profit from elevated patient inflow, particularly for critical hydrocephalus cases that demand specialized treatments. According to Hydrocephalus Association, pediatric hydrocephalus accounts for over 40,000 hospital admissions annually, with nearly 10,000 of these admissions resulting from shunt malfunctions. Moreover, facilities like thorough post-surgical care and advanced technologies also fortifies their position in the hydrocephalus shunt market dynamics. Additionally, strategic partnerships between manufacturers and hospitals facilitates a reliable supply chain, improving latter's pivotal role in this market share.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest hydrocephalus shunts market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for hydrocephalus shunts.

North America is the dominant region in the global hydrocephalus shunts market share primarily due to increasing prevalence of hydrocephalus and cutting-edge healthcare infrastructure. According to USF Health, more than 800,000 Americans are suffering with hydrocephalus, while 1%-5% patients that are suffering with dementia are estimated to have hydrocephalus. The region, particularly United States, is leading in research and development sector and extensive utilization of advanced medical technologies. For instance, Indiana University (IU) in Indianapolis was granted with USD 243 million research fund from the National Institutes of Health in 2023. IU is growing rapidly in R&D and has established Hydrocephalus Research Center that aims to discover hydrocephalus solutions. Canada also has a substantial contribution in the regional market dynamics due to rising patient awareness and robust healthcare policies in the country. This regional domination is also strengthened by preferable pay back policies and an entrenched healthcare providers network.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the hydrocephalus shunts industry include Argi Group, B. Braun Melsungen AG, Christoph Miethke GmbH & Co. KG, G. Surgiwear Ltd., HLL Lifecare Limited, Integra LifeSciences, Kaneka Medix Corporation (Kaneka Corporation), Medtronic Plc, Natus Medical Incorporated, Sophysa, Spiegelberg GmbH & Co. KG (SHS Medizintechnik Holding GmbH) and TKB Corporation.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • The global hydrocephalus shunts market outlook is represented by an intense competition due to the presence of key companies that are dominating the market share through broad product portfolios, innovative technologies, and strategic acquisitions and partnerships. For instance, in July 2023, CereVasc formed a strategic partnership with LianMedical, a China-based medical device company, to release its eShunt system and other related products to providers and patients in East Asian countries China, Hong Kong, Taiwan, and Macaw. Emerging companies are establishing their positions by emphasizing on cost-efficient product formulations and advancements in technology. Regional competitors also contribute substantially, utilizing regulatory policies and local market expertise. Robust research and development, coupled with continuous striving to improve patient outcomes, further fuel the competition and contribute to market evolution.

Key Questions Answered in This Report

  • 1.What was the size of the global hydrocephalus shunts market in 2024?
  • 2.What is the expected growth rate of the global hydrocephalus shunts market during 2025-2033?
  • 3.What has been the impact of COVID-19 on the global hydrocephalus shunts market?
  • 4.What are the key factors driving the global hydrocephalus shunts market?
  • 5.What is the breakup of the global hydrocephalus shunts market based on the type?
  • 6.What is the breakup of the global hydrocephalus shunts market based on the product type?
  • 7.What is the breakup of the global hydrocephalus shunts market based on the age group?
  • 8.What is the breakup of the global hydrocephalus shunts market based on the end user?
  • 9.What are the key regions in the global hydrocephalus shunts market?
  • 10.Who are the key players/companies in the global hydrocephalus shunts market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Hydrocephalus Shunts Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Ventriculo-Peritoneal
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Ventriculo-Atrial
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Ventriculo-Pleural
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Lumbo-Peritoneal
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Product Type

  • 7.1 Hydrocephalus Valves
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Adjustable Pressure Valves
      • 7.1.2.2 Fix Pressure Valves
    • 7.1.3 Market Forecast
  • 7.2 Hydrocephalus Catheters
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Age Group

  • 8.1 Infants
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Children
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Adults
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgical Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Argi Group
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 B. Braun Melsungen AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Christoph Miethke GmbH & Co. KG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 G. Surgiwear Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 HLL Lifecare Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Integra LifeSciences
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Kaneka Medix Corporation (Kaneka Corporation)
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Medtronic Plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Natus Medical Incorporated
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sophysa
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Spiegelberg GmbH & Co. KG (SHS Medizintechnik Holding GmbH)
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 TKB Corporation
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio